Company Infinity Pharmaceuticals, Inc.
Equities
INFI.Q
US45665G3039
Biotechnology & Medical Research
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
0.000001 USD | -.--% | -.--% | -99.96% |
Mar. 25 | North American Morning Briefing : Tech in Focus on -2- | DJ |
Mar. 25 | Infinity Pharmaceuticals, Inc. Went Out of Business | CI |
Business Summary
Number of employees: 30
Sales per Business
USD in Million | 2021 | Weight | 2022 | Weight | Delta |
---|---|---|---|---|---|
Drug Development
100.0
%
| 2 | 100.0 % | 3 | 100.0 % | +39.56% |
Sales per region
USD in Million | 2021 | Weight | 2022 | Weight | Delta |
---|---|---|---|---|---|
United States
100.0
%
| 2 | 100.0 % | 3 | 100.0 % | +39.56% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Seth Tasker
CEO | Chief Executive Officer | 45 | 08-02-29 |
Jennifer Roberts
PRN | Corporate Officer/Principal | - | 17-09-30 |
Melissa Hackel
PRN | Corporate Officer/Principal | - | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Anthony Evnin
BRD | Director/Board Member | 83 | 06-08-31 |
Norman Selby
BRD | Director/Board Member | 71 | 12-03-11 |
David W. Beier
BRD | Director/Board Member | 75 | 18-03-31 |
Richard Gaynor
BRD | Director/Board Member | 74 | 20-03-15 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 90,761,081 | 88,284,669 ( 97.27 %) | 0 | 97.27 % |
Company contact information
Infinity Pharmaceuticals, Inc.
1100 Massachusetts Avenue 4th Floor
02138, Cambridge
+617 453 1000
http://www.infi.comSector
1st Jan change | Capi. | |
---|---|---|
-99.96% | 90 | |
+43.36% | 58.06B | |
-5.31% | 40.53B | |
+37.52% | 38.99B | |
+14.75% | 26.7B | |
-12.56% | 26.56B | |
-22.45% | 18.98B | |
+0.04% | 12.17B | |
+25.12% | 12B | |
+26.04% | 11.92B |
- Stock Market
- Equities
- INFI.Q Stock
- Company Infinity Pharmaceuticals, Inc.